Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
GBT Global Blood Therapeutics, Inc. daily Stock Chart
GBT [NASD]
Global Blood Therapeutics, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-3.89 Insider Own2.30% Shs Outstand60.10M Perf Week19.32%
Market Cap4.77B Forward P/E- EPS next Y-4.49 Insider Trans-4.04% Shs Float58.66M Perf Month67.79%
Income-220.00M PEG- EPS next Q-1.22 Inst Own13.19% Short Float13.24% Perf Quarter56.51%
Sales- P/S- EPS this Y-23.20% Inst Trans14.40% Short Ratio7.82 Perf Half Y38.63%
Book/sh10.95 P/B7.25 EPS next Y-6.70% ROA-32.30% Target Price98.63 Perf Year70.02%
Cash/sh10.04 P/C7.91 EPS next 5Y37.00% ROE-35.30% 52W Range34.92 - 77.95 Perf YTD93.30%
Dividend- P/FCF- EPS past 5Y-30.20% ROI- 52W High1.80% Beta1.66
Dividend %- Quick Ratio14.90 Sales past 5Y- Gross Margin- 52W Low127.23% ATR3.75
Employees171 Current Ratio14.90 Sales Q/Q- Oper. Margin- RSI (14)91.17 Volatility5.98% 6.31%
OptionableYes Debt/Eq0.00 EPS Q/Q-29.80% Profit Margin- Rel Volume1.76 Prev Close76.15
ShortableYes LT Debt/Eq0.00 EarningsNov 19 AMC Payout- Avg Volume992.98K Price79.35
Recom1.80 SMA2036.60% SMA5051.78% SMA20047.37% Volume1,737,698 Change4.20%
Nov-25-19Resumed Cantor Fitzgerald Overweight $110 → $98
Nov-06-19Initiated Canaccord Genuity Hold $50
May-29-19Resumed Goldman Neutral
Dec-03-18Reiterated H.C. Wainwright Buy $125 → $150
Aug-06-18Initiated Piper Jaffray Overweight $80
Jun-27-18Reiterated H.C. Wainwright Buy $73 → $125
Jun-27-18Reiterated Cantor Fitzgerald Overweight $69 → $96
May-08-18Reiterated SunTrust Buy $80 → $77
Mar-21-18Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-28-18Reiterated Cantor Fitzgerald Overweight $61 → $72
Feb-14-18Initiated Janney Buy
Jan-23-18Initiated William Blair Outperform
Dec-14-17Reiterated Needham Buy $51 → $70
Dec-01-17Initiated H.C. Wainwright Buy $73
Sep-21-17Initiated Needham Buy $51
Aug-08-17Reiterated JP Morgan Overweight $44 → $46
Apr-18-17Initiated SunTrust Buy $56
Mar-21-17Resumed Wedbush Outperform $73
Mar-16-17Initiated Cantor Fitzgerald Overweight $61
Mar-02-17Initiated Instinet Buy $50
Dec-07-19 11:31AM  Why Is Global Blood (GBT) Up 68.2% Since Last Earnings Report? Zacks
Dec-06-19 10:03AM  Did Hedge Funds Drop The Ball On Global Blood Therapeutics Inc (GBT)? Insider Monkey
Dec-04-19 08:00AM  GBT Announces New Employment Inducement Grants GlobeNewswire
Dec-02-19 10:17AM  Global Blood Therapeutics Is Poised to Rally Further in the Months Ahead TheStreet.com
Nov-29-19 12:15PM  Biotech Tops in November: Best ETFs & Stocks Zacks
11:30AM  The Zacks Analyst Blog Highlights: GLD, CRSP, GBT, ALNY and ARKG Zacks
11:24AM  The Zacks Analyst Blog Highlights: Intercept, CymaBay, Amgen, Global Blood Therapeutics and ChemoCentryx Zacks
09:26AM  Global Blood (GBT) in Focus: Stock Moves 5.2% Higher Zacks
Nov-27-19 05:33PM  Why Gold is Headed to Zero -- And What You Should Buy Instead Zacks +5.19%
10:09AM  Biotech Stock Roundup: CBAY Falls, CCXI Gains, Amgen Acquires Otezla & More Zacks
07:26AM  The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen Benzinga
03:28AM  Global Blood's (GBT) Oxbryta Secures FDA Approval for SCD Zacks
Nov-26-19 07:06PM  Why Biotech ETFs Surged in Monday's Trading Session Zacks +5.07%
04:15PM  This Biotech Broke Out Bullishly But Couldn't Hold Onto That Gain Investor's Business Daily
08:53AM  Global Blood Therapeutics stock is up on sickle cell therapy approval MarketWatch
08:06AM  The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug Benzinga
08:00AM  GBT Announces Participation at Upcoming Investor Conferences in December GlobeNewswire
Nov-25-19 04:49PM  Could An Earlier-Than-Expected Approval Send This Biotech Into A Breakout? Investor's Business Daily +6.79%
04:03PM  FDA Approves Oxbryta (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease GlobeNewswire
03:56PM  UPDATE 3-FDA approves Global Blood Therapeutics sickle cell disease drug Reuters
03:32PM  FDA approves Global Blood Therapeutics's sickle cell disease drug Reuters
Nov-18-19 04:43PM  Ties to Bay Area drug companies could help (or not) this latest presidential hopeful American City Business Journals
09:36AM  Novartis Receives FDA Nod for Adakveo in Sickle Cell Disease Zacks
Nov-08-19 10:00AM  Global Blood's (GBT) Q3 Loss Widens, Voxelotor in Focus Zacks
Nov-07-19 04:05PM  GBT Reports Recent Business Progress and Third Quarter 2019 Financial Results GlobeNewswire
Nov-06-19 09:00AM  GBT Announces Upcoming Data Presentations at 61st American Society of Hematology Annual Meeting & Exposition GlobeNewswire -5.02%
Nov-04-19 08:00AM  GBT Announces New Employment Inducement Grants GlobeNewswire
Oct-24-19 02:15PM  Hedge Funds Have Never Been More Bullish On Global Blood Therapeutics Inc (GBT) Insider Monkey
Oct-21-19 08:00AM  GBT Announces Results of Post-hoc Analysis of Phase 3 HOPE Study Showing Improvement in Leg Ulcers in Patients with Sickle Cell Disease Treated with Voxelotor GlobeNewswire
Oct-18-19 10:23AM  These 24 Bay Area drug and diagnostics companies quietly raised nearly $3B this year American City Business Journals
Oct-07-19 08:00AM  GBT Announces New Employment Inducement Grants GlobeNewswire
Oct-02-19 08:00AM  GBT Announces Upcoming Presentations at the 47th Annual National Sickle Cell Disease Association of America (SCDAA) Convention GlobeNewswire
Oct-01-19 08:00AM  GBT to Host Analyst & Investor Day on October 8 in New York GlobeNewswire
Sep-25-19 08:00AM  GBT Announces Participation at the 2019 Cantor Global Healthcare Conference GlobeNewswire
Sep-19-19 12:48PM  When Will Loss-Maker Global Blood Therapeutics, Inc. (NASDAQ:GBT) Need More Cash? Simply Wall St.
Sep-11-19 10:23AM  3 Hot Biotechs with High Upside Potential TipRanks +5.53%
Sep-06-19 11:53AM  FDA Grants Priority Review to Global Blood's SCD Candidate Zacks
09:31AM  Why Is Global Blood (GBT) Up 6.2% Since Last Earnings Report? Zacks
Sep-05-19 05:19PM  Why Global Blood Therapeutics Stock Jumped 10.9% Today Motley Fool +10.89%
04:34PM  Why This Biotech Stock Just Vaulted Over Its 50-Day Moving Average Investor's Business Daily
Sep-04-19 08:00AM  GBT Announces New Employment Inducement Grants GlobeNewswire
Sep-03-19 04:05PM  GBT Announces Participation at the 2019 Morgan Stanley Global Healthcare Conference GlobeNewswire
08:45AM  Global Blood Focuses on Lead Candidate Amid Competition Zacks
08:00AM  GBT and Sickle Cell Disease Association of America to Host 8th Annual Sickle Cell Disease (SCD) Therapeutics Conference GlobeNewswire
Aug-07-19 04:05PM  GBT Reports Recent Business Progress and Second Quarter 2019 Financial Results GlobeNewswire
Aug-06-19 08:00AM  GBT Announces Participation at the 2019 Wedbush PacGrow Healthcare Conference GlobeNewswire
Aug-02-19 08:00AM  GBT Announces New Employment Inducement Grants GlobeNewswire
Jul-25-19 01:03PM  5 Biotech Stocks to Buy for Blockbuster Potential Kiplinger
Jul-16-19 06:05PM  Should You Pick Up Novartis (NVS) Before Q2 Earnings? Zacks
10:07AM  Novartis' (NVS) Crizanlizumab Gets Priority Review From FDA Zacks
Jul-10-19 08:00AM  GBT and Advocates Launch Disease Awareness Campaign Focused on Breaking Down Stigmas Associated with Sickle Cell Disease GlobeNewswire
Jul-09-19 08:00AM  GBT Announces New Employment Inducement Grants GlobeNewswire
Jul-05-19 08:01AM  Local researcher part of 'exciting' sickle cell drug trial American City Business Journals
Jun-26-19 04:41PM  Why BlackBerry, AeroVironment, and Global Blood Therapeutics Slumped on Wednesday Motley Fool -13.34%
08:50AM  Global Blood Therapeutics Prices a $200.0 Million Common Stock Public Offering GlobeNewswire
07:19AM  The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart Benzinga
Jun-25-19 04:14PM  Global Blood Therapeutics Announces Proposed Public Offering of Common Stock GlobeNewswire
Jun-23-19 08:00AM  Should You Be Concerned About Global Blood Therapeutics, Inc.'s (NASDAQ:GBT) Historical Volatility? Simply Wall St.
Jun-19-19 10:54AM  Is Global Blood Therapeutics Inc (GBT) A Good Stock To Buy? Insider Monkey
Jun-14-19 02:37PM  Global Blood Therapeutics Stock Options Hot During Sell-Off Schaeffer's Investment Research -6.15%
02:32AM  GBT Announces Updated 24-Week Efficacy Data from All Patients Enrolled in Phase 3 HOPE Study Showing Statistically Significant and Sustained Improvements in Hemoglobin with Voxelotor GlobeNewswire
Jun-13-19 08:28AM  Options Traders Expect Huge Moves in Global Blood Therapeutics (GBT) Stock Zacks
08:16AM  A Biotech Stock to Watch Now Motley Fool
Jun-10-19 08:00AM  GBT Awards More than $200,000 in Grants to Five Nonprofit Organizations through New ACCEL Program Aimed at Improving Access to Healthcare for People Living with Sickle Cell Disease GlobeNewswire
Jun-07-19 09:30AM  Why Is Global Blood (GBT) Up 2% Since Last Earnings Report? Zacks
08:00AM  GBT Announces New Employment Inducement Grants GlobeNewswire
May-16-19 09:05AM  GBT Announces Upcoming Data Presentations at 24th European Hematology Association (EHA) Congress Supporting Voxelotor Sickle Cell Disease Program GlobeNewswire
May-10-19 03:27PM  Global Blood (GBT) Reports Narrower-Than-Expected Loss in Q1 Zacks
May-08-19 07:22PM  Global Blood: 1Q Earnings Snapshot Associated Press
04:05PM  GBT Reports Recent Business Progress and First Quarter 2019 Financial Results GlobeNewswire
11:16AM  When Will Global Blood Therapeutics, Inc. (NASDAQ:GBT) Breakeven? Simply Wall St.
May-06-19 08:00AM  GBT Announces New Employment Inducement Grants GlobeNewswire
Apr-30-19 08:14PM  Did Hedge Funds Drop The Ball On Global Blood Therapeutics Inc (GBT) ? Insider Monkey
Apr-03-19 08:00AM  GBT Announces New Employment Inducement Grants GlobeNewswire +6.86%
Apr-02-19 08:00AM  GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference GlobeNewswire
Mar-08-19 01:31PM  Announcing: Global Blood Therapeutics (NASDAQ:GBT) Stock Increased An Energizing 211% In The Last Three Years Simply Wall St.
Mar-06-19 08:00AM  GBT Announces New Employment Inducement Grants GlobeNewswire -5.80%
Mar-04-19 08:25AM  Detailed Research: Economic Perspectives on Intelsat S.A, Sprint, Restaurant Brands International, Tower Semiconductor, TE Connectivity, and Global Blood Therapeutics What Drives Growth in Today's Competitive Landscape GlobeNewswire
08:00AM  GBT Announces Participation at the Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Feb-28-19 09:28AM  Aiming at genetic diseases, Peninsula stealth biotech emerges with $191 million American City Business Journals
Feb-27-19 04:05PM  GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2018 Financial Results GlobeNewswire
Feb-21-19 08:00AM  GBT Announces Participation at the 8th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-19-19 08:00AM  GBT Launches ACCEL Grants Program to Improve Access to Care for People with Sickle Cell Disease GlobeNewswire
Feb-05-19 10:52AM  Why Global Blood Therapeutics Surged 16.7% Higher in January Motley Fool
08:00AM  GBT Announces New Employment Inducement Grants GlobeNewswire
Feb-01-19 09:48AM  6 Biotech Stocks to Watch Now Motley Fool
Jan-29-19 04:05PM  GBT Announces Publication of Data from Phase 1/2 Study of Voxelotor in Patients with Sickle Cell Disease GlobeNewswire
Jan-22-19 06:55PM  Should You Sell CRISPR Therapeutics Following an Analyst Downgrade? Motley Fool
Jan-03-19 04:05PM  GBT Announces New Employment Inducement Grants GlobeNewswire
Jan-02-19 04:05PM  GBT to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-21-18 01:30PM  GBT Appoints Dawn Svoronos to Board of Directors GlobeNewswire
Dec-13-18 08:32AM  Ghost Tree Capitals AUM, Returns and Holdings Insider Monkey
Dec-11-18 03:17PM  Top 6 Performing IPOs of 2015 (ONCE, GBT) Investopedia
12:05PM  Here's Why Global Blood Therapeutics Fell 10.1% in November, Then Jumped 37% Since Motley Fool
Dec-10-18 07:15AM  Global Blood Therapeutics, Voxelotor in Advanced Clinicals, Analysts Review and Target ACCESSWIRE
Dec-07-18 09:15AM  Global Blood Therapeutics Prices a $150.0 Million Common Stock Public Offering GlobeNewswire -8.60%
08:04AM  The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut Benzinga
07:00AM  3 Biotech Stocks That Could Explode Higher in 2019 SmarterAnalyst
Dec-06-18 04:05PM  Global Blood Therapeutics Announces Proposed Public Offering of Common Stock GlobeNewswire
01:48PM  3 Top Stocks After #ASH18 Motley Fool
Global Blood Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities. It is developing its lead product candidate, voxelotor, an oral, once-daily therapy for sickle cell disease (SCD). The company is evaluating voxelotor in SCD in a Phase III clinical trial in adult and adolescent patients with SCD. It is also evaluating the safety and pharmacokinetics of single and multiple doses of voxelotor in a Phase IIa clinical trial of adolescent and pediatric patients with SCD. Global Blood Therapeutics, Inc. was founded in 2011 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUVARI TRICIA BORGAChief Legal OfficerDec 02Sale66.743,434229,1856,752Dec 03 07:18 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 26Option Exercise59.6011,593690,94311,593Nov 27 04:47 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 26Sale67.1911,593778,9340Nov 27 04:47 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 25Option Exercise25.6410,930280,2394,594Nov 27 04:47 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 25Sale60.0010,930655,8000Nov 27 04:47 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 19Option Exercise48.446,562317,8636,562Nov 20 06:11 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 19Sale55.006,562360,9100Nov 20 06:11 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 18Option Exercise26.9065617,646656Nov 20 06:11 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 18Sale50.6365633,2130Nov 20 06:11 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 15Option Exercise25.749,948256,0749,948Nov 18 05:43 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 15Sale50.009,948497,4470Nov 18 05:43 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 14Option Exercise20.003296,580329Nov 18 05:43 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 14Sale50.0132916,4550Nov 18 05:43 PM
SUVARI TRICIA BORGAChief Legal OfficerNov 01Sale48.453,327161,19210,186Nov 05 04:05 PM
PATRICK DEVAL LDirectorOct 08Option Exercise3.405,35718,2145,357Oct 10 04:52 PM
PATRICK DEVAL LDirectorOct 08Sale45.055,357241,3330Oct 10 04:52 PM
SUVARI TRICIA BORGAChief Legal OfficerOct 01Sale48.703,249158,22613,513Oct 02 07:22 PM
Calhoun Lesley AnnSee RemarksSep 11Sale54.362,765150,296887Sep 13 04:45 PM
Calhoun Lesley AnnSee RemarksFeb 12Sale50.4535417,8601,032Feb 14 05:29 PM
open in yahoo | open in reuters | open in google